| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 1314081-53-2 | 维卡格雷
Vicagrel | |
C18H18ClNO4S | 379.86 |
| 851366-97-7 | 磷酸糖原合酶肽2(底物)，三氟乙酸盐
Phospho-Glycogen Synthase Peptide-2(substrate) TFA | |
C124H194F3N40O50P | 3133.0701 |
| 168635-85-6 | 癌胚抗原
Carcinoembryonic Antigen CEA | |
C43H69N11O14 | 965.08 |
| 2225940-48-5 | 泊马度胺 4'-烷基C4-酸
Pomalidomide 4'-alkylC4-acid | |
C18H19N3O6 | 373.37 |
| 936544-53-5 | 棕榈酰三肽-8 TFA盐
Palmitoyl Tripeptide-8 TFA salt | |
C37H61N9O4(free) | 695.940(free) |
| 156250-74-7 | 哈茨木霉 A
Harzianum A | |
C23H28O6 | 400.47 |
| 171777-72-3 | 叶酸-d4
Folic Acid-d4 | |
C19H15D4N7O6 | 445.42 |
| 1804978-81-1 | YNT-185
| |
C33H37N5O5S | 615.74 |
| 2564467-16-7 | VH 101 酚烷基C6-胺
(2S,4R)-N-[[2-(6-aminohexoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide;dihydrochloride | |
C32H46FN5O5S·2HCl | 704.72 |
| 2415256-17-4 | VH 032酰胺-烷基C7-胺二盐酸盐
VH 032 amide-alkylC7-amine dihydrochloride | |
C30H47Cl2N5O4S | 644.7 |
| 2415256-20-9 | VH 032酰胺-烷基C5-胺 二盐酸盐
VH 032 amide-alkylC5-amine dihydrochloride | |
C28H41N5O4S·2HCl | 616.64 |
| 2098799-78-9 | VH 032,炔丙基
VH 032,propargyl | |
C27H34N4O5S | 526.55 |
| 2172819-77-9 | VH 032 酰胺-烷基C8-酸
VH 032 amide-alkylC8-acid | |
| |
| 2564467-25-8 | VH 032 酰胺-烷基C3-胺
VH 032 amide-alkylC3-amine | |
| |
| 169675-08-5 | Ro60-0175
| |
C11H12ClFN2 | 226.68 |
| 342779-66-2 | NCRW0005-F05
| |
C16H13F2NO2 | 289.28 |
| 217480-27-8 | N2-[[2-(2-Naphthalenyl)-1H-benz[g]indol-3-yl]acetyl-D-lysine (2S)-2-aminopropyl ester
| |
C33H36N4O3 | 536.66 |
| 190078-50-3 | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide TFA
| |
| |
| 862974-25-2 | N-(4-甲氧基苯并[d]噻唑-2-基)-5-(4-甲氧基苯基)-1,3,4-噁二唑-2-胺
N106 | |
| |
| 313254-94-3 | MMG 11,TLR2拮抗剂
MMG 11 | |
| |
| 4549-02-4 | Maculosin
| 熔点：156-159 °C
沸点：581.4±43.0 °C(Predicted)
|
C14H16N2O3·xCF3COOH | 260.29(free) |
| 1155866-55-9 | LDV TFA
| |
C48H70N10O12 | 979.13 |
| 217480-26-7 | L-803,087三氟乙酸盐
L-803,087 trifluoroacetate | |
C27H30F5N5O5 | 599.56 |
| 877874-85-6 | KG 5,PDGFRβ，B-Raf，c-Raf，FLT3和KIT抑制剂
KG 5 | |
C20H16F3N7OS | 459.45 |
| 1009344-33-5 | KCNQ2/3 activator-1
| |
C23H29FN2O | 368.50 |
| 88039-46-7 | INF 4E,半胱天冬酶-1和NLRP3炎性体抑制剂
INF 4E | |
C12H13ClO3 | 240.68 |
| 60793-01-3 | HEPC
| |
C23H48NO5PS | 481.7 |
| 494191-73-0 | GPR35 agonist 2
| |
C17H11FN2O3S | 342.34 |
| 926281-37-0 | GGsTop,γ-谷氨酰转肽酶(GGT)抑制剂
GGsTop | |
C13H18NO7P | 331.26 |
| 1094451-90-7 | G 28UCM,FASN抑制剂
G 28UCM | |
C24H16O10 | 464.38 |
| 329691-12-5 | FPR A14
| |
C23H20N2O5 | 404.42 |
| 1781834-93-2 | FIPI,磷脂酶D抑制剂
FIPI | |
| |
| 145040-29-5 | FGIN-1-43,线粒体DBI受体的有效特异性配体
FGIN-1-43 | |
C28H36Cl2N2O | 487.51 |
| 54635-62-0 | EMD 386088
| |
C14H15ClN2 | 246.74 |
| 151126-84-0 | CL-316243二钠盐
CL-316243 disodium salt | |
C20H18ClNNa2O7 | 465.8 |
| 1839150-56-9 | CHMFL-FLT3-122,FLT3抑制剂
CHMFL-FLT3-122 | |
C26H29N7O2 | 471.57 |
| 110368-33-7 | Ch 55,RAR激动剂
Ch 55 | |
C24H28O3 | 364.48 |
| 724440-27-1 | BAY-8002
| |
C20H14ClNO5S | 415.85 |
| 83027-13-8 | AMN082 free base
| |
C28H28N2 | 392.54 |
| 324029-01-8 | AKTide-2T TFA
| |
C74H114N28O20 | 1715.89 |
| 875910-01-3 | AGA-(C8R)HNG17,humanin derivative TFA
| |
C80H135F3N20O26 | 1850.04 |
| 133550-41-1 | 酪氨酸磷酸化抑制剂
AG 556 | |
C20H20N2O3 | 336.3845 |
| 848591-90-2 | A 582941,α7nAChR部分激动剂
A 582941 | |
C17H20N4 | 280.37 |
| 369656-76-8 | 2′-脱氧尿苷-13C，15N2
2′-Deoxyuridine-¹³C,¹⁵N2 | |
| |
| 50939-69-0 | 19-O-Acetylchaetoglobosin A
| |
C34H38N2O6 | 570.7 |
| 191349-10-7 | 19,20-环氧细胞松弛素D
19,20-Epoxycytochalasin D | |
C30H37NO7 | 523.6173 |
| 97760-87-7 | 1-[4-氨基-3-氯-5-(三氟甲基)苯基]-2-溴-乙酮
1-[4-Amino-3-chloro-5-(trifluoromethyl)phenyl]-2-bromo-ethanone | |
| |
| 55779-26-5 | 1-(BETA-羧基乙基)-3,3-二甲基-6'-硝基螺(吲哚啉-2,2'-2H-苯并吡喃)
1-(beta-carboxyethyl)-3,3-dimethyl-6'-nitrospiro(indoline- 2,2'-2H-benzopyran) | 密度：1.40±0.1 g/cm3(Predicted)
熔点：199-200 °C
沸点：588.7±50.0 °C(Predicted)
|
C21H20N2O5 | 380.4 |
| 14689-84-0 | 1,5-二磷酸-D-核酮糖
D-ribulose 1,5-diphosphate | |
C5H12O11P2 | 310.09 |
| 2066488-39-7 | (S)-C33,PDE9抑制剂
(S)-C33 | |
C18H20ClN5O | 357.84 |
